Symbol="ADAG"
AssetType="Common Stock"
Name="Adagene Inc"
Description="Adagene Inc., a clinical-stage biopharmaceutical company, is dedicated to the research, development, and production of monoclonal antibody drugs for cancer. The company is headquartered in Suzhou, China."
CIK="1818838"
Exchange="NASDAQ"
Currency="USD"
Country="China"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4F, BUILDING C14, NO. 218, XINGHU STREET, SUZHOU INDUSTRIAL PARK, JIANGSU, CHINA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="53622000"
EBITDA="-82471152"
PERatio="None"
PEGRatio="None"
BookValue="1.933"
DividendPerShare="0"
DividendYield="0"
EPS="-1.81"
RevenuePerShareTTM="0.215"
ProfitMargin="0"
OperatingMarginTTM="-9.03"
ReturnOnAssetsTTM="-0.307"
ReturnOnEquityTTM="-0.667"
RevenueTTM="9292700"
GrossProfitTTM="10175300"
DilutedEPSTTM="-1.81"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.391"
AnalystTargetPrice="12.53"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.499"
PriceToBookRatio="0.433"
EVToRevenue="0.0853"
EVToEBITDA="1.262"
Beta="0.202"
num_52WeekHigh="2.1"
num_52WeekLow="0.9"
num_50DayMovingAverage="1.363"
num_200DayMovingAverage="1.431"
SharesOutstanding="43772700"
DividendDate="None"
ExDividendDate="None"
symbol="ADAG"
open="1.23"
high="1.25"
low="1.18"
price="1.18"
volume="3441.00"
latest_trading_day="2023-08-30"
previous_close="1.18"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="62"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="19937"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.77"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="1110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_negative_thumbnail_id_2="92"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="954"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_positive_thumbnail_id_2="991"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
